These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28849128)

  • 1. In silico design of colchicine-based bioisosteric inhibitors of tubulin for the treatment of rheumatoid arthritis.
    Wang L; Yang HJ; Tu R; Shen M; Liu D
    Mol Med Rep; 2017 Oct; 16(4):4823-4828. PubMed ID: 28849128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New ligands of the tubulin colchicine site based on X-ray structures.
    Álvarez R; Medarde M; Peláez R
    Curr Top Med Chem; 2014; 14(20):2231-52. PubMed ID: 25434358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of small molecule inhibitors that interact with γ-tubulin.
    Friesen DE; Barakat KH; Semenchenko V; Perez-Pineiro R; Fenske BW; Mane J; Wishart DS; Tuszynski JA
    Chem Biol Drug Des; 2012 May; 79(5):639-52. PubMed ID: 22268380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into the design of indole derivatives as tubulin polymerization inhibitors.
    Li Y; Yang J; Niu L; Hu D; Li H; Chen L; Yu Y; Chen Q
    FEBS Lett; 2020 Jan; 594(1):199-204. PubMed ID: 31369682
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hadizadeh F; Ghodsi R; Mirzaei S; Sahebkar A
    Comput Math Methods Med; 2022; 2022():4004068. PubMed ID: 35075369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tubulin colchicine domain: a molecular modeling perspective.
    Massarotti A; Coluccia A; Silvestri R; Sorba G; Brancale A
    ChemMedChem; 2012 Jan; 7(1):33-42. PubMed ID: 21990124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical and experimental study of polycyclic aromatic compounds as β-tubulin inhibitors.
    Olazarán FE; García-Pérez CA; Bandyopadhyay D; Balderas-Rentería I; Reyes-Figueroa AD; Henschke L; Rivera G
    J Mol Model; 2017 Mar; 23(3):85. PubMed ID: 28214932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
    Coluccia A; Sabbadin D; Brancale A
    Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
    Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
    J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.
    Wang Y; Zhang H; Gigant B; Yu Y; Wu Y; Chen X; Lai Q; Yang Z; Chen Q; Yang J
    FEBS J; 2016 Jan; 283(1):102-11. PubMed ID: 26462166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
    Bhattacharyya B; Panda D; Gupta S; Banerjee M
    Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.
    Yin Y; Qiao F; Jiang LY; Wang SF; Sha S; Wu X; Lv PC; Zhu HL
    Bioorg Med Chem; 2014 Aug; 22(15):4285-92. PubMed ID: 24916028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site.
    Dong M; Liu F; Zhou H; Zhai S; Yan B
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27754459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site.
    Li L; Jiang S; Li X; Liu Y; Su J; Chen J
    Eur J Med Chem; 2018 May; 151():482-494. PubMed ID: 29649743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation impacts on the bioactivities of SMART analogues.
    Wu Y; Guan Q; Zheng D; Yan P; Feng D; Du J; Zhang J; Zuo D; Bao K; Zhang W
    Eur J Med Chem; 2018 Oct; 158():733-742. PubMed ID: 30245397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
    Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
    Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of a benzylidene derivative of 9(10H)-anthracenone in complex with tubulin provides a rationale for drug design.
    Cheng J; Wu Y; Wang Y; Wang C; Wang Y; Wu C; Zeng S; Yu Y; Chen Q
    Biochem Biophys Res Commun; 2018 Jan; 495(1):185-188. PubMed ID: 29102632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
    Zhang X; Kong Y; Zhang J; Su M; Zhou Y; Zang Y; Li J; Chen Y; Fang Y; Zhang X; Lu W
    Eur J Med Chem; 2015 May; 95():127-35. PubMed ID: 25805446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of BODIPY-labeled colchicine.
    Arnold LA; Ranaivo P; Guy RK
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5867-70. PubMed ID: 18684625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Computational Analysis of Indomethacin Derivative as Tubulin Inhibitor: Insights into Development of Chemotherapeutic Agents.
    Costa KM; Alves CN; Silva JR; Lameira J
    Comb Chem High Throughput Screen; 2016; 19(6):431-6. PubMed ID: 27141989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.